Fauci and Rand Paul clash over Wuhan lab's controversial virus research in Senate hearing

published 20 July 2021

Dr. Anthony Fauci and Sen. Rand Paul (R) are taking the gloves off.

The National Institute of Allergy and Infectious Diseases chief and Kentucky senator verbally sparred during a Senate hearing on Tuesday, after Paul accused the National Institutes of Health of lying about funding controversial research at the Wuhan Institute of Virology. Paul claimed the research could have contributed to the COVID-19 pandemic, The Hill and CNBC report.

Paul has made such assertions before, but it appears that Fauci is done playing nice. After vehemently discrediting Paul's remarks, Fauci accused the senator of not knowing "what you are talking about, quite frankly, and I want to say that officially. You do not know what you are talking about." Fauci has previously denied that the NIH directly funded the research at the Wuhan lab, per CNBC, and on Tuesday, said the study Paul is referring to does not constitute the controversial gain-of-function research.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

After Paul doubled down on his claims, Fauci fired back: "If the point that you are making is that the grant that was funded ... created SARS-CoV-2 ... I totally resent the lie you are now propagating, senator."

The Kentucky senator countered that he's simply trying to ascertain whether the NIH funded such research, but Fauci criticized the question's underlying implications. "And you are implying that what we did was responsible for the deaths of [individuals], I totally resent that, and if anybody is lying here, senator, it is you."

Watch the full exchange below:

Explore More

Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.